Trials / Completed
CompletedNCT04702451
Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 377 (actual)
- Sponsor
- Volta Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Atrial Fibrillation (AF) ablation is typically performed in predefined anatomic regions of the left atrium without attempting to identify patient-specific areas of interest. This procedure is referred to as Pulmonary Vein Isolation (PVI). The hypothesis in this Study is that a tailored ablation strategy targeting areas of spatio-temporal dispersion in combination with PVI is superior to an anatomical ablation strategy targeting PVI alone for the treatment of persistent AF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Dispersion ablation + PVI | Ablation of spatio-temporal dispersion electrograms in combination with pulmonary vein antrum isolation |
| DEVICE | VX1 | VX1-based dispersion mapping |
| PROCEDURE | PVI | Pulmonary vein antrum isolation |
Timeline
- Start date
- 2021-02-12
- Primary completion
- 2023-12-27
- Completion
- 2023-12-27
- First posted
- 2021-01-08
- Last updated
- 2025-09-12
- Results posted
- 2025-09-12
Locations
26 sites across 5 countries: United States, Belgium, France, Germany, Netherlands
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04702451. Inclusion in this directory is not an endorsement.